LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation

Authors: Asad Ali, Katia Grillone, Serena Ascrizzi, Giulio Caridà, Lucia Fiorillo, Domenico Ciliberto, Nicoletta Staropoli, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Di Martino

Source: Molecular Therapy: Nucleic Acids, Vol 35, Iss 2, Pp 102221- (2024)

Subject Terms: MT: Oligonucleotides: Therapies and Applications, microRNAs, miRNA, miRNA inhibition, miR-221, LNA-i-miR-221, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2162253124001082; https://doaj.org/toc/2162-2531

Access URL: https://doaj.org/article/3da076c66b4d4799a8feb9a8d50480d2

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study

Authors: Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, Lucia Fiorillo, Nicoletta Staropoli, Domenico Ciliberto, Alessia Cordua, Francesca Scionti, Bernardo Bertucci, Angela Salvino, Mariangela Lopreiato, Fredrik Thunarf, Onofrio Cuomo, Maria Cristina Zito, Maria Rosanna De Fina, Amelia Brescia, Simona Gualtieri, Caterina Riillo, Francesco Manti, Daniele Caracciolo, Vito Barbieri, Eugenio Donato Di Paola, Adele Emanuela Di Francesco, Pierosandro Tagliaferri

Source: Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)

Subject Terms: miRNA therapeutics, microRNA, miRNA, RNA therapeutics, Non-coding RNA therapeutics, miR-221, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1756-8722

Access URL: https://doaj.org/article/4d9a753abc2e49c2bbde30064f04d177

First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis

Authors: Domenico Ciliberto, Giulio Caridà, Nicoletta Staropoli, Caterina Romeo, Grazia Maria Arillotta, Cristina Napoli, Luigia Gervasi, Francesco Luciano, Caterina Riillo, Pierfrancesco Tassone, Pierosandro Tagliaferri

Source: Heliyon, Vol 9, Iss 8, Pp e18696- (2023)

Subject Terms: HCC, Advanced hepatocellular carcinoma, TKI, ICI, Sorafenib, Lenvatinib, Science (General), Q1-390, Social sciences (General), H1-99

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844023059042; https://doaj.org/toc/2405-8440

Access URL: https://doaj.org/article/fb2e6fd54a394d6ab96df15017f50d9f

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity

Authors: Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza, Martina Costa, Giacomo Rossini, Francesco Manti, Antonella Crispino, Caterina Riillo, Domenico Ciliberto, Mariamena Arbitrio, Pierfrancesco Tassone, Pierosandro Tagliaferri

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: advanced endometrial cancer, immunotherapy, targeted therapy, pembrolizumab, lenvatinib, lung toxicity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1145986/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/ff6871284696474fbf16f570be46d30f

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

Authors: Giovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, Roberta Depenni, Nicola Fazio, Luca Galli, Dario Giuffrida, Carlo Carnaghi, Domenico Ciliberto, Domenico C. Corsi, Paola Queirolo, Elena Benincasa, Filippo Venturini, Gennaro Fazzi, Nuno Costa, Paolo Antonio Ascierto

Source: Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-11 (2021)

Subject Terms: Avelumab, Merkel cell carcinoma, Second line, Expanded access program, PD-L1, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1479-5876

Access URL: https://doaj.org/article/f52e875346f74ef69cff61e898b81684

A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics

Authors: Nicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, Francesca Scionti, Domenico Ciliberto, Rossana Ingargiola, Caterina Labanca, Giuseppe Agapito, Eleonora Iuliano, Vito Barbieri, Maria Cucè, Valeria Zuccalà, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri

Source: Biomedicines, Vol 10, Iss 5, p 1210 (2022)

Subject Terms: advanced ovarian cancer, targeted therapy, carboplatin, DMET analysis, prognostic factors, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/10/5/1210; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/243e782ecef8418599fd7cdcc76fa73a

GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

Authors: Michele Caraglia, Pierpaolo Correale, Rocco Giannicola, Nicoletta Staropoli, Cirino Botta, Pierpaolo Pastina, Antonello Nesci, Nadia Caporlingua, Edoardo Francini, Laura Ridolfi, Enrico Mini, Giandomenico Roviello, Domenico Ciliberto, Rita Maria Agostino, Alessandra Strangio, Domenico Azzarello, Valerio Nardone, Antonella Falzea, Salvatore Cappabianca, Marco Bocchetti, Graziella D'Arrigo, Giovanni Tripepi, Pierfrancesco Tassone, Raffaele Addeo, Antonio Giordano, Luigi Pirtoli, Guido Francini, Pierosandro Tagliaferri

Source: Frontiers in Oncology, Vol 9 (2019)

Subject Terms: colorectal cancer, metastatic, chemotherapy, immunotherapy, GOLFIG, phase III clinical trial, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fonc.2019.01102/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/7170bd6fde8f4eec8eb14aa1cf9dfeb1

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients

Authors: Cirino Botta, Domenico Ciliberto, Marco Rossi, Nicoletta Staropoli, Maria Cucè, Teresa Galeano, Pierosandro Tagliaferri, Pierfrancesco Tassone

Source: Blood Advances, Vol 1, Iss 7, Pp 455-466 (2017)

Subject Terms: Specialties of internal medicine, RC581-951

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2473952920303955; https://doaj.org/toc/2473-9529

Access URL: https://doaj.org/article/a9933654fa4144e5a8505e5bfb2216ee

Panitumumab Induced Forearm Panniculitis in Two Women With Metastatic Colon Cancer

Authors: Domenico, Ciliberto, Antonella, Ierardi, Benedetto, Caroleo, Luigi, Scalise, Antonio, Cimellaro, Lidia, Colangelo, Giuseppe, Spaziano, Gallelli, Luca

Source: Current drug safety. 14(3):233-237

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100090525448.0x000001&indx=1&recIds=ETOCvdc_100090525448.0x000001